Advertisement

You will be redirected to the page you want to view in  seconds.

Lunesta manufacturer Sunovion Pharmaceuticals will lower the starting dose of the tablet. / JB Reed Bloomberg News via Getty

WASHINGTON (AP) - U.S. health officials say the maker of Lunesta must lower the starting dose of its sleeping aid drug due to risks of morning drowsiness, which can interfere with driving ability and lead to injury.

The Food and Drug Administration is taking action based on a study that found Lunesta at recommended doses can cause problems with driving, memory and coordination up to 11 hours after the drug is taken. Patients are often unaware that they are still drowsy.

Lunesta manufacturer Sunovion Pharmaceuticals will lower the starting dose of the tablet to 1 milligram from 2 milligrams. Patients can increase the dose, but should remember that higher doses are more likely to cause impairment the next day, according to the FDA.

Drowsiness is a side effect for all anti-insomnia drugs.



Copyright 2014 USATODAY.com

Read the original story: FDA calls for lower first dose of Lunesta for sleep

More In

test

Real Deals

Flip, shop and save on specials from your favorite retailers in central Ohio.

GET DEALS | COUPONS

Things To Do

FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WED
29
THU
30

CLASSIFIEDS

Classifieds from across Central Ohio
Lancaster
Chillicothe
Newark
Marion
Bucyrus
Mansfield
Zanesville
Coshocton

Weeklies & Shoppers

10TV Headlines

Dispatch Headlines

METROMIX